ProPhase Labs, Inc. Accrued Vacation, Current
ProPhase Labs, Inc. (PRPH) had Accrued Vacation, Current of $4.00 thousand as of 2020-12-31, per its 10-K filed 2021-03-31.
Discontinued › Notes › Accrued Liabilities, Current
us-gaap:AccruedVacationCurrent · last filed 2021-03-31
- 2020-12-31: Accrued Vacation, Current $4.00K.
- 2020-09-30: Accrued Vacation, Current $17.00K.
- 2020-06-30: Accrued Vacation, Current $11.00K.
- 2020-03-31: Accrued Vacation, Current $20.00K.
| Period end | Accrued Vacation, Current |
|---|---|
| 2020-12-31 | $4.00K 10-K · filed 2021-03-31 |
| 2020-09-30 | $17.00K 10-Q · filed 2020-11-19 |
| 2020-06-30 | $11.00K 10-Q · filed 2020-08-11 |
| 2020-03-31 | $20.00K 10-Q · filed 2020-05-12 |
| 2019-12-31 | $5.00K 10-K · filed 2021-03-31 |
| 2019-09-30 | $29.00K 10-Q · filed 2019-11-12 |
| 2019-06-30 | $51.00K 10-Q · filed 2019-08-12 |
| 2019-03-31 | $62.00K 10-Q · filed 2019-05-14 |
| 2018-12-31 | $66.00K 10-K · filed 2020-03-26 |
| 2018-09-30 | $74.00K 10-Q · filed 2018-11-14 |
| 2018-06-30 | $81.00K 10-Q · filed 2018-08-20 |
| 2018-03-31 | $78.00K 10-Q/A · filed 2018-08-20 |
| 2017-12-31 | $88.00K 10-K · filed 2019-03-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| Processa Pharmaceuticals, Inc. (PCSA) | United States | $0.005B | |
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B | |
| Dermata Therapeutics, Inc. (DRMA) | United States | $0.005B | -0.62 |
| REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH) | United States | $0.005B | |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |